Efficacy and Safety of Probiotics in Neonatal Hyperbilirubinemia
Efficacy and Safety of Probiotics in Neonatal Hyperbilirubinemia
Neonatal Jaundice occurs in 60% of term infants and 80% of premature infants. Although it is
 transient, it is associated with high rate of readmission of patients in the first week of
 infancy. Neonatal jaundice can cause neurological complications and kernicterus. Considering
 the fact that there have been a lot of studies on probiotic role in management of necrotizing
 enterocolitis (NEC) and few studies on their role in neonatal jaundice, we carried out this
 study to determine the efficacy and safety of probiotics in neonatal hyperbilirubinemia in
 infants hospitalized in children hospital in Bandar Abbas.
Inclusion Criteria:

 -  Between 2 and 28 days old

 -  Having jaundice

 -  Gestational age between 35-42 weeks

 Exclusion Criteria:

 -  Less than 2 days or more than 28 days old

 -  Gestational age out of the range of 35-42 weeks

 -  Infants whose parents refused to cooperate

 -  Patients with sepsis and other comorbid conditions